BOUDREAUX GAIL — SEC Form 4 filings
SEC reporting owner CIK 1287920. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-05 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 2 filings — 11,225 shares, $3,441,181 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 1 filing — 34,000 shares, $17,033,395 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 20,779 shares @ $500.36 ($10,396,980) in Elevance Health, Inc., filed 2024-07-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Elevance Health, Inc. (ELV) | President and CEO, Director | 6 | 5 legs · 11,225 sh · $3,441,181 | 6 legs · 34,000 sh · $17,033,395 | 13 |
| TARGET CORP (TGT) | Director | 3 | — | — | 3 |
Form 4 filings — BOUDREAUX GAIL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Elevance Health, Inc. (ELV) | Purchase (P): 680 @ $366.41 · Purchase (P): 2,045 @ $368.25 | EDGAR |
| 2026-03-13 | 4 | TARGET CORP (TGT) | Grant/award (A): 2,682 @ $0 | EDGAR |
| 2026-03-04 | 4 | Elevance Health, Inc. (ELV) | Tax withholding (F): 6,713 @ $294.07 · Grant/award (A): 16,153 @ $0 · Grant/award (A): 10,527 @ $0 · Tax withholding (F): 1,736 @ $284.03 · Grant/award (A): 63,818 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Elevance Health, Inc. (ELV) | Purchase (P): 2,334 @ $286.07 · Purchase (P): 5,116 @ $287.12 · Purchase (P): 1,050 @ $287.96 | EDGAR |
| 2025-03-14 | 4 | TARGET CORP (TGT) | Grant/award (A): 2,946 @ $0 | EDGAR |
| 2025-03-05 | 4 | Elevance Health, Inc. (ELV) | Tax withholding (F): 10,396 @ $395.50 · Grant/award (A): 10,620 @ $0 · Grant/award (A): 15,587 @ $0 · Grant/award (A): 40,429 (derivative) @ $0 | EDGAR |
| 2024-07-23 | 4 | Elevance Health, Inc. (ELV) | Sale (S): 1,100 @ $498.50 · Sale (S): 20,779 @ $500.36 · Sale (S): 6,621 @ $501.40 · Sale (S): 2,250 @ $502.23 · Sale (S): 1,000 @ $503.67 · Sale (S): 2,250 @ $504.27 | EDGAR |
| 2024-03-15 | 4 | TARGET CORP (TGT) | Grant/award (A): 1,873 @ $0 | EDGAR |
| 2024-03-05 | 4 | Elevance Health, Inc. (ELV) | Tax withholding (F): 19,256 @ $499.11 · Grant/award (A): 8,415 @ $0 · Grant/award (A): 34,517 @ $0 · Grant/award (A): 32,480 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1287920 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →